An analysis of RASSF1 expression profiles in colorectal adenocarcinoma (COAD) and rectal adenocarcinoma (READ) by the GEPIA web-based tool (Supplementary Figure S1a) revealed modest underexpression in patients, though this was not statistically significant. Here, RASSF1 is linked to rectum adenocarcinoma.